Understand the bottlenecks, impurity control challenges, and yield improvement needs that customers encounter in specific API synthesis pathways.
Communicating GMP document requirements (e.g., CoA, MOA, DMF/CEP support), supplier audit details, specific impurity spectrum control standards, etc.
Demonstrating our expertise and understanding of specific intermediates and their applications, positioning ourselves as a trusted ‘technical advisor’ rather than merely a product supplier.
Stay informed about the client's R&D pipeline progress (preclinical, clinical stages), commercial production plans, performance of existing suppliers, and potential switching points.
Collect feedback on-site and coordinate internal resources more quickly to address sudden quality issues, supply shortages, or urgent order requirements.
The procurement decision-making process for pharmaceutical intermediates is complex, involving strict regulatory requirements (GMP), a thorough understanding of complex synthesis processes, and quality control. Our sales and technical teams engage in high-frequency, high-quality communication with customers to understand:
